Stamatios Theocharis Selected Research

Stamatios Theocharis Research Topics

Disease

110	Neoplasms (Cancer) 07/2022 - 06/2002
22	Carcinogenesis 06/2022 - 12/2008
15	Neoplasm Metastasis (Metastasis) 03/2022 - 09/2007
12	Inflammation (Inflammations) 06/2022 - 09/2009
11	Adenocarcinoma 07/2019 - 06/2002
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2017 - 02/2011
9	Colonic Neoplasms (Colon Cancer) 11/2019 - 06/2002
8	Carcinoma (Carcinomatosis) 10/2021 - 06/2002
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2019 - 06/2002
7	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2012
7	Reperfusion Injury 05/2021 - 09/2008
6	Pancreatic Neoplasms (Pancreatic Cancer) 09/2021 - 05/2009
5	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 10/2009
4	Pituitary Neoplasms (Pituitary Adenoma) 09/2022 - 12/2008
4	Endometrial Neoplasms (Endometrial Cancer) 03/2022 - 01/2013
4	Melanoma (Melanoma, Malignant) 03/2022 - 05/2021
4	Lung Neoplasms (Lung Cancer) 08/2018 - 06/2002
4	Atherosclerosis 05/2017 - 01/2011
4	Carotid Artery Diseases 10/2012 - 07/2010
4	Atherosclerotic Plaque (Atheroma) 12/2011 - 03/2007
3	Lung Injury 01/2022 - 01/2016
3	Uveal melanoma 05/2021 - 09/2020
3	Ischemia 05/2021 - 09/2008
3	Kidney Diseases (Kidney Disease) 01/2020 - 07/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2017 - 11/2008
3	Disease Progression 03/2017 - 07/2011
3	Lymphatic Metastasis 01/2017 - 03/2010
3	Infections 01/2014 - 03/2010
3	Pain (Aches) 08/2013 - 02/2011
3	Liver Diseases (Liver Disease) 12/2012 - 05/2007
2	Pneumonia (Pneumonitis) 01/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2006
2	Triple Negative Breast Neoplasms 05/2019 - 10/2018
2	Adenoma (Adenomas) 03/2018 - 01/2018
2	Glioma (Gliomas) 01/2018 - 06/2015
2	Neuroblastoma 05/2017 - 12/2014
2	Sepsis (Septicemia) 01/2014 - 11/2004
2	Adenocarcinoma of Lung 10/2012 - 06/2002

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 03/2022 - 06/2002
25	Biomarkers (Surrogate Marker)IBA 04/2022 - 10/2009
21	LigandsIBA 05/2022 - 06/2002
12	AntigensIBA 09/2021 - 06/2008
12	PPAR gammaIBA 10/2012 - 06/2002
11	EphrinsIBA 05/2022 - 08/2013
11	Histone Deacetylase InhibitorsIBA 03/2022 - 10/2011
11	Pharmaceutical PreparationsIBA 03/2022 - 02/2011
9	Histone Deacetylases (Histone Deacetylase)IBA 03/2022 - 02/2013
9	Eph Family Receptors (Eph Receptors)IBA 02/2022 - 09/2011
8	Biological ProductsIBA 01/2021 - 06/2002
6	ParaffinIBA 10/2021 - 06/2008
5	MicroRNAs (MicroRNA)IBA 04/2022 - 11/2016
5	EnzymesIBA 08/2021 - 09/2008
4	Pregnane X ReceptorIBA 10/2021 - 01/2013
4	Messenger RNA (mRNA)IBA 09/2021 - 01/2015
4	LipidsIBA 03/2021 - 01/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 06/2002
4	PaxillinIBA 09/2017 - 12/2014
4	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2017 - 12/2010
4	CannabinoidsIBA 03/2016 - 01/2015
4	EndocannabinoidsIBA 01/2016 - 04/2013
4	Transcription Factors (Transcription Factor)IBA 09/2014 - 05/2009
3	Erythropoietin FDA Link 05/2022 - 03/2022
3	Histones (Histone)IBA 03/2022 - 10/2011
3	CytokinesIBA 01/2022 - 01/2016
3	Phosphotransferases (Kinase)IBA 12/2021 - 04/2015
3	AntioxidantsIBA 05/2021 - 09/2008
3	Immune Checkpoint InhibitorsIBA 05/2021 - 05/2019
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2014
3	Bile Acids and Salts (Bile Acids)IBA 01/2019 - 01/2012
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2018 - 01/2015
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 12/2011
3	Retinoid X Receptors (Retinoid X Receptor)IBA 10/2015 - 05/2009
3	Matrix Metalloproteinases (MMPs)IBA 04/2015 - 12/2008
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2012 - 02/2011
3	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2010 - 11/2008
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2022 - 08/2012
2	tyrosine receptor (receptor, tyrosine)IBA 04/2022 - 12/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 08/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2016
2	ELAV-Like Protein 1IBA 01/2022 - 01/2021
2	Phenobarbital (Luminal)FDA Link 10/2021 - 07/2018
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 09/2021 - 07/2018
2	CarcinogensIBA 01/2021 - 06/2006
2	AzoxymethaneIBA 10/2020 - 06/2018
2	Dextran SulfateIBA 10/2020 - 06/2018
2	CD40 Ligand (CD40L)IBA 10/2020 - 01/2018
2	Cyclin EIBA 11/2019 - 05/2009
2	Retinoblastoma ProteinIBA 11/2019 - 09/2003
2	CyclinsIBA 11/2019 - 09/2003
2	AdipokinesIBA 01/2019 - 01/2018
2	Antigen Receptors (Antigen Receptor)IBA 07/2018 - 01/2015
2	LeptinIBA 01/2018 - 05/2007
2	C-Reactive ProteinIBA 01/2018 - 01/2014
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 04/2013
2	GhrelinIBA 04/2014 - 04/2013
2	Thioacetamide (Thioacetamid)IBA 12/2012 - 09/2008

Therapy/Procedure

22	Therapeutics 06/2022 - 04/2006
11	Drug Therapy (Chemotherapy) 05/2022 - 11/2004
5	Immunotherapy 05/2021 - 05/2019
2	Endoscopes 09/2022 - 06/2022